Condensed Balance Sheets - USD ($)	Jun. 30, 2018	Dec. 31, 2017
Current Assets:
Cash and cash equivalents	$ 11,683,729	$ 12,959,373
Accounts receivable	384,951	297,039
Inventories, net	247,624	201,155
Prepaid expenses and other	462,782	388,275
Total Current Assets	12,779,086	13,845,842
Restricted cash	75,000	52,000
Deferred Offering Costs	49,042
Equipment, net	163,849	77,150
Total Assets	13,066,977	13,974,992
Current Liabilities:
Accounts payable and other accrued expenses	1,399,335	1,277,236
Derivative liabilities	21,962	39,930
Deferred revenue	149,086	168,006
Total Current Liabilities	1,570,383	1,485,172
Deferred revenue, net of current portion	45,496	44,042
Total Liabilities	1,615,879	1,529,214
Commitments and Contingencies
Stockholders’ Equity:
Common stock par value $0.0001 per share 100,000,000 shares authorized; 12,414,958 and 11,139,667 shares issued as June 30, 2018 and December 31, 2017, respectively, and 12,414,150 and 11,138,859 shares outstanding as of June 30, 2018 and December 31, 2017, respectively.	1,241	1,114
Undesignated preferred stock par value $0.0001 per share; 25,000,000 authorized at June 30, 2018 and December 31, 2017, respectively. No shares issued or outstanding.
Additional paid-in capital	51,404,071	47,423,915
Accumulated deficit	(39,947,750)	(34,972,787)
Treasury stock, at cost; 808 shares of common stock at June 30, 2018 and December 31, 2017.	(6,464)	(6,464)
Total Stockholders’ Equity	11,451,098	12,445,778
Total Liabilities and Stockholders’ Equity	$ 13,066,977	$ 13,974,992